James Reddoch's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 100,000 Class A Ordinary Shares done at an average price of $41.2 . Disclosure was reported to the exchange on Sept. 28, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma PLC (Class A) | James Reddoch | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 41.23 per share. | 28 Sep 2022 | 100,000 | 820,800 | - | 41.2 | 4,122,670 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | James Reddoch | EVP & Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Sep 2022 | 2,400 | 478,870 | - | - | LP interests in RPI US Partners 2019, LP | |
| Royalty Pharma PLC (Class A) | James Reddoch | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 41.56 per share. | 08 Jun 2022 | 100,000 | 920,800 | - | 41.6 | 4,155,900 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | James Reddoch | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 41.08 per share. | 27 May 2022 | 75,000 | 1,020,800 | - | 41.1 | 3,081,008 | Class A Ordinary Shares |
| Royalty Pharma PLC (Class A) | James Reddoch | EVP & Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 40.44 per share. | 19 May 2022 | 75,000 | 1,095,800 | - | 40.4 | 3,033,128 | Class A Ordinary Shares |